By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ra Pharma  

One Kendall Square
Building 1400 West, 3rd Floor
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-401-4060 Fax: 617-401-4061


Key Statistics

Ownership: Public

Web Site: Ra Pharma
Symbol: RARX

Company News
Ra Pharma (RARX) Reports First Quarter 2017 Financial Results And Provides Corporate Update 5/12/2017 6:30:25 AM
Ra Pharma (RARX) Initiates Dosing Of RA101495 In PNH Patients 4/26/2017 6:13:24 AM
Ra Pharma (RARX) Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update 3/7/2017 6:32:34 AM
Ra Pharma (RARX) Supports 10th Annual Rare Disease Day And Joins Global Movement To Raise Awareness For Rare Diseases 2/28/2017 7:26:31 AM
Ra Pharma (RARX) Reports Third Quarter 2016 Financial Results And Provides Corporate Update 11/30/2016 11:08:50 AM
Ra Pharma (RARX) Receives Orphan Drug Designation In The European Union For RA101495 For Treatment Of Paroxysmal Nocturnal Hemoglobinuria 11/17/2016 11:30:53 AM
Ra Pharma (RARX)'s $92 Million Debut is the Ninth Massachusetts Biotech IPO of 2016 10/27/2016 6:29:55 AM
Ra Pharma Announces Pricing Of Initial Public Offering 10/26/2016 10:16:02 AM
Massachusetts VC-Backed Biotech Ra Pharma Files for $86 Million IPO 10/3/2016 6:06:48 AM
Ra Pharma Presents Clinical Data On Complement C5 Inhibitor RA101495 At The 21st Congress Of The European Hematology Association 6/10/2016 8:02:04 AM